Physician profile
Brian Weinstein
NPI 1952700841
$576.33
in general payments reported to CMS, 2019-2025
11 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.00 · 2023: $151 · 2024: $123 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.06 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $128.36 | 2025 | Nemluvio |
| Lilly USA, LLC | $81.14 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Amgen INC. | $73.87 | 2023-2025 | Otezla, Otezla |
| Davol INC. | $72.21 | 2022-2023 | Phasix Mesh |
| Abbvie INC. | $67.28 | 2024-2025 | |
| Journey Medical Corporation | $52.92 | 2024-2025 | |
| Genzyme Corporation | $25.55 | 2023 | |
| Verrica Pharmaceuticals INC. | $21.84 | 2024 | Ycanth |
| Almirall LLC | $18.97 | 2025 | Klisyri |
| Arcutis Biotherapeutics, INC. | $18.92 | 2023 | |
| Pfizer INC. | $15.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.